Literature DB >> 22170566

Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.

Mengfei Ho1, Cheong-Hian Goh, Michael C Brothers, Shihua Wang, Ryan L Young, Yuxiang Ou, Juliana Nga-Man Lui, Marinos Kalafatis, Xiuwan Lan, Abigail E Wolf, Chad M Rienstra, Brenda A Wilson.   

Abstract

The light chain of botulinum neurotoxin A (BoNT/A-LC) is a Zn-dependent protease that specifically cleaves SNAP25 of the SNARE complex, thereby impairing vesicle fusion and neurotransmitter release at neuromuscular junctions. The C-terminus of SNAP25 (residues 141-206) retains full activity for BoNT/A-LC-catalyzed cleavage at P1-P1' (Gln197-Arg198). Using the structure of a complex between the C-terminus of SNAP25 and BoNT/A-LC as a model to design SNAP25-derived pseudosubstrate inhibitors (SNAPIs) that prevent presentation of the scissile bond to the active site, we introduced multiple His residues to replace Ala-Asn-Gln-Arg (residues 195-198) at the substrate cleavage site, with the intent to identify possible side-chain interactions with the active site Zn. We also introduced multiple Gly residues between the P1-P1' residues to explore the spatial tolerance within the active-site cleft. Using a FRET substrate YsCsY, we compared a series of SNAPIs for inhibition of BoNT/A-LC. Among the SNAPIs tested, several known cleavage-resistant, single-point mutants of SNAP25 were poor inhibitors, with most of the mutants losing binding affinity. Replacement with His at the active site did not improve inhibition over wildtype substrate. In contrast, Gly-insertion mutants were not only resistant to cleavage, but also surprisingly showed enhanced affinity for BoNT/A-LC. Two of the Gly-insertion mutants exhibited 10-fold lower IC₅₀ values than the wildtype 66-mer SNAP25 peptide. Our findings illustrate a scenario, where the induced fit between enzyme and bound pseudosubstrate fails to produce the strain and distortion required for catalysis to proceed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22170566      PMCID: PMC3375433          DOI: 10.1002/pro.2017

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation.

Authors:  Daniel S Chertow; Esther T Tan; Susan E Maslanka; Joann Schulte; Eddy A Bresnitz; Richard S Weisman; Jeffrey Bernstein; Steven M Marcus; Savita Kumar; Jean Malecki; Jeremy Sobel; Christopher R Braden
Journal:  JAMA       Date:  2006-11-22       Impact factor: 56.272

2.  Mechanism of substrate recognition by botulinum neurotoxin serotype A.

Authors:  Sheng Chen; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2007-01-23       Impact factor: 5.157

Review 3.  Gaining ground: assays for therapeutics against botulinum neurotoxin.

Authors:  Ramin Mollaaghababa Hakami; Gordon Ruthel; Andrea M Stahl; Sina Bavari
Journal:  Trends Microbiol       Date:  2010-03-04       Impact factor: 17.079

4.  Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex.

Authors:  Nicholas R Silvaggi; David Wilson; Saul Tzipori; Karen N Allen
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

5.  Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism.

Authors:  Arvind Raghunath; Francesc Perez-Branguli; Leonard Smith; J Oliver Dolly
Journal:  J Neurosci       Date:  2008-04-02       Impact factor: 6.167

6.  Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A.

Authors:  Desigan Kumaran; Richa Rawat; Matthew L Ludivico; S Ashraf Ahmed; Subramanyam Swaminathan
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

7.  Tandem fluorescent proteins as enhanced FRET-based substrates for botulinum neurotoxin activity.

Authors:  Melissa Pires-Alves; Mengfei Ho; Karla K Aberle; Kim D Janda; Brenda A Wilson
Journal:  Toxicon       Date:  2009-03-15       Impact factor: 3.033

8.  A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate.

Authors:  Jorge E Zuniga; James J Schmidt; Timothy Fenn; James C Burnett; Demet Araç; Rick Gussio; Robert G Stafford; Shirin S Badie; Sina Bavari; Axel T Brunger
Journal:  Structure       Date:  2008-10-08       Impact factor: 5.006

9.  Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain.

Authors:  Axel T Brunger; Mark A Breidenbach; Rongsheng Jin; Audrey Fischer; Jose S Santos; Mauricio Montal
Journal:  PLoS Pathog       Date:  2007-09-07       Impact factor: 6.823

10.  Substrate binding mode and its implication on drug design for botulinum neurotoxin A.

Authors:  Desigan Kumaran; Richa Rawat; S Ashraf Ahmed; Subramanyam Swaminathan
Journal:  PLoS Pathog       Date:  2008-09-26       Impact factor: 6.823

View more
  4 in total

Review 1.  Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

2.  Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.

Authors:  Yongfeng Fan; Isin N Geren; Jianbo Dong; Jianlong Lou; Weihua Wen; Fraser Conrad; Theresa J Smith; Leonard A Smith; Mengfei Ho; Melissa Pires-Alves; Brenda A Wilson; James D Marks
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 3.  Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity.

Authors:  Elena Fonfria; Mark Elliott; Matthew Beard; John A Chaddock; Johannes Krupp
Journal:  Toxins (Basel)       Date:  2018-07-04       Impact factor: 4.546

4.  Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.

Authors:  Yongfeng Fan; Jianbo Dong; Jianlong Lou; Weihua Wen; Fraser Conrad; Isin N Geren; Consuelo Garcia-Rodriguez; Theresa J Smith; Leonard A Smith; Mengfei Ho; Melissa Pires-Alves; Brenda A Wilson; James D Marks
Journal:  Toxins (Basel)       Date:  2015-08-26       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.